{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T15:47:54Z","timestamp":1791128874068,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.antiviral.2009.10.015","type":"journal-article","created":{"date-parts":[[2009,10,28]],"date-time":"2009-10-28T04:17:02Z","timestamp":1256703422000},"page":"121-127","source":"Crossref","is-referenced-by-count":64,"title":["Efficacy of favipiravir (T-705) and T-1106 pyrazine derivatives in phlebovirus disease models"],"prefix":"10.1016","volume":"86","author":[{"given":"Brian B.","family":"Gowen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Hui","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kie-Hoon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald F.","family":"Smee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Morrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousuke","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2009.10.015_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/rtph.1998.1201","article-title":"Serum transaminase elevations as indicators of hepatic injury following the administration of drugs","volume":"27","author":"Amacher","year":"1998","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.antiviral.2009.10.015_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF01310749","article-title":"Pathogenesis of a phleboviral infection (Punta Toro virus) in golden Syrian hamsters","volume":"114","author":"Anderson","year":"1990","journal-title":"Arch. Virol."},{"key":"10.1016\/j.antiviral.2009.10.015_bib3","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical and public health management","volume":"287","author":"Borio","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.antiviral.2009.10.015_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4269\/ajtmh.2003.69.269","article-title":"Induction of severe disease in hamsters by two sandfly fever group viruses, Punta toro and Gabek Forest (Phlebovirus, Bunyaviridae), similar to that caused by Rift Valley fever virus","volume":"69","author":"Fisher","year":"2003","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2009.10.015_bib5","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1128\/AAC.46.4.977-981.2002","article-title":"In vitro and in vivo activities of anti-influenza virus compound T-705","volume":"46","author":"Furuta","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2009.10.015_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.antiviral.2009.02.198","article-title":"T-705 (favipiravir) and related compounds: novel broad-spectrum inhibitors of RNA viral infections","volume":"82","author":"Furuta","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2009.10.015_bib7","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1038\/nm1142","article-title":"Exotic emerging viral diseases: progress and challenges","volume":"10","author":"Geisbert","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2009.10.015_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.antiviral.2008.09.001","article-title":"Prophylaxis with cationic liposome\u2013DNA complexes protects hamsters from phleboviral disease: importance of liposomal delivery and CpG motifs","volume":"81","author":"Gowen","year":"2009","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2009.10.015_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.antiviral.2005.12.002","article-title":"Protective immunity against acute phleboviral infection elicited through immunostimulatory cationic liposome\u2013DNA complexes","volume":"69","author":"Gowen","year":"2006","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2009.10.015_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.antiviral.2007.10.002","article-title":"Animal models of highly pathogenic RNA viral infections: hemorrhagic fever viruses","volume":"78","author":"Gowen","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2009.10.015_bib11","doi-asserted-by":"crossref","first-page":"e3725","DOI":"10.1371\/journal.pone.0003725","article-title":"Treatment of late stage disease in a model of arenaviral hemorrhagic Fever: T-705 efficacy and reduced toxicity suggests an alternative to ribavirin","volume":"3","author":"Gowen","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.antiviral.2009.10.015_bib12","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1128\/AAC.01473-05","article-title":"Recombinant Eimeria protozoan protein elicits resistance to acute phlebovirus infection in mice but not hamsters","volume":"50","author":"Gowen","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2009.10.015_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.antiviral.2007.12.002","article-title":"Prophylactic and therapeutic intervention of Punta Toro virus (Phlebovirus, Bunyaviridae) infection in hamsters with interferon alfacon-1","volume":"77","author":"Gowen","year":"2008","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2009.10.015_bib14","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1128\/AAC.00356-07","article-title":"In vitro and in vivo activities of T-705 against Arenavirus and Bunyavirus Infections","volume":"51","author":"Gowen","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2009.10.015_bib15","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.4049\/jimmunol.178.8.5200","article-title":"TLR3 is essential for the induction of protective immunity against Punta Toro Virus infection by the double-stranded RNA (dsRNA), poly(I:C12U), but not Poly(I:C): differential recognition of synthetic dsRNA molecules","volume":"178","author":"Gowen","year":"2007","journal-title":"J. Immunol."},{"issue":"Suppl. 4","key":"10.1016\/j.antiviral.2009.10.015_bib16","doi-asserted-by":"crossref","first-page":"S750","DOI":"10.1093\/clinids\/11.Supplement_4.S750","article-title":"Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad-spectrum antiviral drug","volume":"11","author":"Huggins","year":"1989","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.antiviral.2009.10.015_bib17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1128\/AAC.01074-08","article-title":"Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106","volume":"53","author":"Julander","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2009.10.015_bib18","unstructured":"Morrey, J.D., Taro, B., Siddharthan, V., Wang, H., Smee, D.F., Christensen, A.J., Furuta, Y. Efficacy of orally administered T-705 pyrazine analog on lethal West Nile virus infection in rodents. Antiviral Res., in press."},{"key":"10.1016\/j.antiviral.2009.10.015_bib19","series-title":"Epidemiology and Pathogenesis of the Rift Valley Fever and Other Phleboviruses","author":"Morrill","year":"1996"},{"key":"10.1016\/j.antiviral.2009.10.015_bib20","series-title":"Textbook of Human Virology","first-page":"547","article-title":"Bunyaviruses, phleboviruses, and related viruses","author":"Peters","year":"1984"},{"key":"10.1016\/j.antiviral.2009.10.015_bib21","series-title":"Handbook Series of Zooneses","first-page":"403","article-title":"Rift Valley fever","author":"Peters","year":"1981"},{"key":"10.1016\/j.antiviral.2009.10.015_bib22","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0166-3542(86)90024-0","article-title":"Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator","volume":"6","author":"Peters","year":"1986","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2009.10.015_bib23","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/0882-4010(87)90011-8","article-title":"Punta Toro virus infection of C57BL\/6J mice: a model for phlebovirus-induced disease","volume":"3","author":"Pifat","year":"1987","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.antiviral.2009.10.015_bib24","first-page":"493","article-title":"A simple method of estimating fifty percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."},{"key":"10.1016\/j.antiviral.2009.10.015_bib25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4269\/ajtmh.2004.71.306","article-title":"Efficacy of post-exposure treatment of yellow fever with ribavirin in a hamster model of the disease","volume":"71","author":"Sbrana","year":"2004","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.antiviral.2009.10.015_bib26","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1128\/AAC.01051-06","article-title":"Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in mice","volume":"51","author":"Sidwell","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2009.10.015_bib27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1128\/AAC.32.3.331","article-title":"In vitro and in vivo Phlebovirus inhibition by ribavirin","volume":"32","author":"Sidwell","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2009.10.015_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0166-3542(91)90069-4","article-title":"Prophylactic and therapeutic activities of 7-thia-8-oxoguanosine against Punta Toro virus infections in mice","volume":"15","author":"Smee","year":"1991","journal-title":"Antiviral Res."},{"key":"10.1016\/j.antiviral.2009.10.015_bib29","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1086\/320199","article-title":"Experimental yellow fever virus infection in the Golden Hamster (Mesocricetus auratus). I. Virologic, biochemical, and immunologic studies","volume":"183","author":"Tesh","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2009.10.015_bib30","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1086\/320200","article-title":"Experimental yellow fever virus infection in the Golden Hamster (Mesocricetus auratus). II. Pathology","volume":"183","author":"Xiao","year":"2001","journal-title":"J. Infect. Dis."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354209005026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354209005026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T07:58:54Z","timestamp":1558598334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354209005026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0166354209005026"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2009.10.015","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}